Outlook Therapeutics is trading 5.48% up at $0.52 in after-hours trading on October 19, 2026, consistent with a broad biotech rebound; no company-specific catalyst was identified.
- The XBI was up 2.77% at 1:28 p.m. ET.
- The latest company press release found was the October 9 appointment of a chief commercial officer.